A rare case of Epstein‐Barr virus‐associated hepatosplenic smooth muscle tumors after kidney transplantation | Zendy

Pircher C. | Zendy; Schneeberger S. | Zendy; Boesmueller C. | Zendy; Agaimy A. | Zendy; Zoller H. | Zendy; Bale R. | Zendy; Henninger B. | Zendy; Mayer G. | Zendy; Neuwirt H. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

A rare case of Epstein‐Barr virus‐associated hepatosplenic smooth muscle tumors after kidney transplantation

Author(s) -

Pircher C.,

Schneeberger S.,

Boesmueller C.,

Agaimy A.,

Zoller H.,

Bale R.,

Henninger B.,

Mayer G.,

Neuwirt H.

Publication year - 2018

Publication title -

transplant infectious disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.69

H-Index - 67

eISSN - 1399-3062

pISSN - 1398-2273

DOI - 10.1111/tid.12860

Subject(s) - medicine , immunosuppression , sirolimus , tacrolimus , radiofrequency ablation , transplantation , kidney transplantation , kidney , virus , liver transplantation , epstein–barr virus , spleen , pathology , surgery , ablation , immunology

A 27‐year old caucasian male was diagnosed 2.7 years after kidney transplantation with Epstein‐Barr virus ( EBV )‐associated smooth muscle tumors in liver and spleen. The reduction in immunosuppression and conversion from tacrolimus to sirolimus did not lead to a regression of the tumors. Additionally, the patient developed a cellular rejection of his renal allograft, which was successfully treated. A combined approach with stereotactic radiofrequency ablation ( SRFA ) and surgical resection was effective in the treatment of the tumors.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research